The first trial in which evidence was taken in the mass tort litigation over Risperdal, the antipsychotic drug that plaintiffs have claimed causes males to grow breasts, was settled as part of a group of five cases that resolved this week for undisclosed amounts, according to the plaintiffs’ lawyers and a statement from the drugmakers. The case of A.B. v. Janssen Pharmaceuticals was in its second week of trial before Philadelphia Court of Common Pleas Judge Mark I. Bernstein. A staffer in Bernstein’s chambers confirmed the settlement.

[pdf-embedder url=”http://sheller.com/wp-content/uploads/2015/07/Legal_Intel_10_5_12_Risperdal_Trial_Ends_in_Settlement_Six_Cases_Total.pdf”]